Literature DB >> 12091367

Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3).

Vinod Devalia1, Kymberley Carter, Ann P Walker, Stephen J Perkins, Mark Worwood, Alison May, James S Dooley.   

Abstract

We describe a family with autosomal dominant inheritance of increased body iron stores characterized by raised serum ferritin concentration and normal transferrin saturation. Liver biopsy showed iron deposition in Kupffer cells without fibrosis. The clinical features of HFE-related hemochromatosis were absent, as were the Cys282Tyr and His63Asp mutations. Venesection therapy was poorly tolerated, suggesting a defect in iron release from reticuloendothelial stores. A 3-base pair deletion in exon 5 of the ferroportin 1 gene (SLC11A3) predicting Val162 deletion was found in affected members, but not in unaffected individuals or in 100 control subjects. Consensus structural predictions of the transmembrane helices showed that the deletion is in the extracellular loop between the third and fourth predicted transmembrane helices and lies within a spatial cluster of other known ferroportin 1 mutations. These results indicate that this extracellular cluster is functionally important for iron transport, and its disruption leads to iron overload.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091367     DOI: 10.1182/blood-2001-11-0132

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Identification of ferroportin disease in the Indian subcontinent.

Authors:  D F Wallace; P Browett; P Wong; H Kua; R Ameratunga; V N Subramaniam
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

2.  Ferroportin disease due to the A77D mutation in Australia.

Authors:  V N Subramaniam; D F Wallace; J L Dixon; L M Fletcher; D H Crawford
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

3.  SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent.

Authors:  James C Barton; Ronald T Acton; Pauline L Lee; Carol West
Journal:  Blood Cells Mol Dis       Date:  2007-05-09       Impact factor: 3.039

4.  Disease progression and liver cancer in the ferroportin disease.

Authors:  Elena Corradini; Francesca Ferrara; Teresa Pollicino; Alberto Vegetti; Gian Luca Abbati; Luisa Losi; Giovanni Raimondo; Antonello Pietrangelo
Journal:  Gut       Date:  2007-07       Impact factor: 23.059

Review 5.  Hepcidin and its role in iron absorption.

Authors:  K J Robson
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  A mouse model of juvenile hemochromatosis.

Authors:  Franklin W Huang; Jack L Pinkus; Geraldine S Pinkus; Mark D Fleming; Nancy C Andrews
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 7.  The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1).

Authors:  Andrew T McKie; David J Barlow
Journal:  Pflugers Arch       Date:  2003-06-27       Impact factor: 3.657

8.  Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload.

Authors:  Monique G Zaahl; Alison T Merryweather-Clarke; Maritha J Kotze; Schalk van der Merwe; Louise Warnich; Kathryn J H Robson
Journal:  Hum Genet       Date:  2004-08-24       Impact factor: 4.132

Review 9.  Is genetic screening for hemochromatosis worthwhile?

Authors:  Omer T Njajou; Behrooz Z Alizadeh; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient.

Authors:  K E Arden; D F Wallace; J L Dixon; L Summerville; J W Searle; G J Anderson; G A Ramm; L W Powell; V N Subramaniam
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.